TP53 and breast carcinoma: Herein, we describe the characterization of these cell lines in terms of cell morphology, ultrastructure, DNA content, population doubling time (PDT), tumorigenicity, invasive potential, therapeutic sensitivity, protein expression, mycoplasma contamination, TP53 mutation, status karyotype, breast cancer biomarker expression and STR authentication.